Security key
426897302
Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (HEPA)
CUSIP: 426897302
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $.0001 par value
- Total 13F shares
- 16
- Total 13F value
- $11
- Share change
- +16
- SEC-reported price per share
- $0.69
- Number of holders
- 1
- Value change
- +$11
- Number of buys
- 1
- Shares outstanding
- 10,619,449
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
1
Top holders
0
HEPA full security history
Ownership snapshot
Newer quarter: Q4 2025
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897302
Recent filing periods:
Ownership snapshot
Top reported holders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, $.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIGGER CAPITAL FUND L P
Disclosed value leader
Dr. Robert T. Foster
Comparable rows
3/12
Latest evidence
30 Jun 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
9 rows are not safely comparable across share classes.
13D/G row: BIGGER CAPITAL FUND L P
Showing 1-6 of 12 holder rows.
Quick read
BIGGER CAPITAL FUND L P leads the comparable SEC ownership view at 10%.
3 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIGGER CAPITAL FUND L P's linked filing trail.
Comparable ownership
Top 3
BIGGER CAPITAL FUND L P
10%
Anson Funds Management LP
4.9%
XTX Topco Ltd
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P |
13D/G
|
10%
|
$21,218
1,060,883 shares
|
$0 | 21 Jan 2025 |
| Anson Funds Management LP |
13D/G
|
4.9%
|
—
576,482 shares
|
$0 | 30 Jun 2025 |
| XTX Topco Ltd |
13F
Company
|
0.02%
|
$1,389
17,361 shares
|
— | 30 Jun 2025 |
| Dr. Robert T. Foster |
3/4/5
CEO and Director, Director
|
—
class O/S missing
|
$153,934
50,470 shares
|
— | 18 Sep 2023 |
| Peter Wijngaard |
3/4/5
Director
|
—
class O/S missing
|
$28,978
9,501 shares
|
— | 24 Nov 2023 |
| Cavan John T. |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
1,581,060 shares
|
— | 18 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Archived quarter
Historical 13F summary for Q3 2025
This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.